Oral treatment for diabetes using α-glucosidase inhibitors was a risk factor for chronic obstructive pulmonary disease: a cohort study
2016 ◽
Vol 194
(4)
◽
pp. 429-438
◽
2017 ◽
Vol Volume 12
◽
pp. 2425-2432
◽
2011 ◽
Vol 105
(3)
◽
pp. 461-469
◽